Observational studyOncotarget2016

A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies.

Ting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.